MILLER VALUE PARTNERS, LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings102 positions
Amazon.com, Inc. | 79,448 | $119.3M | 5.4% | $75.10 | 0.00% | 1 qtr | First report 0 |
RH COM | 985,635 | $118.1M | 5.4% | $118.96 | 0.00% | 1 qtr | First report 0 |
GENWORTH FINL INC COM SHS | 21.2M | $98.7M | 4.5% | $4.60 | 0.00% | 1 qtr | First report 0 |
BAUSCH HEALTH COS INC | 4.8M | $88.7M | 4.0% | $18.79 | 0.00% | 1 qtr | First report 0 |
ONEMAIN HLDGS INC | 3.2M | $77.4M | 3.5% | $10.70 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co. | 770,686 | $75.2M | 3.4% | $79.22 | 0.00% | 1 qtr | First report 0 |
UNITED AIRLS HLDGS INC | 892,225 | $74.7M | 3.4% | $83.17 | 0.00% | 1 qtr | First report 0 |
DELTA AIR LINES INC DEL | 1.4M | $71.2M | 3.2% | $46.57 | 0.00% | 1 qtr | First report 0 |
ENDO INTL PLC | 9M | $65.3M | 3.0% | — | — | 1 qtr | First report 0 |
LUMEN TECHNOLOGIES INC | 4.2M | $63.4M | 2.9% | $11.11 | 0.00% | 1 qtr | First report 0 |
BRIGHTHOUSE FINL INC | 2M | $62.4M | 2.8% | $31.11 | 0.00% | 1 qtr | First report 0 |
NXP Semiconductors NV | 831,735 | $61M | 2.8% | $64.47 | 0.00% | 1 qtr | First report 0 |
TEVA PHARMACEUTICAL INDS LTD | 3.9M | $60.3M | 2.7% | $15.69 | 0.00% | 1 qtr | First report 0 |
QUOTIENT TECHNOLOGY INC | 5.6M | $59.8M | 2.7% | — | — | 1 qtr | First report 0 |
PULTE GROUP INC | 2.3M | $59.1M | 2.7% | $24.16 | 0.00% | 1 qtr | First report 0 |
Meta Platforms Inc | 448,480 | $58.8M | 2.7% | $129.85 | 0.00% | 1 qtr | First report 0 |
ADT INC DEL | 9.6M | $57.7M | 2.6% | $4.83 | 0.00% | 1 qtr | First report 0 |
LENNAR CORP | 1.5M | $57.4M | 2.6% | $34.90 | 0.00% | 1 qtr | First report 0 |
CELGENE CORP | 836,195 | $53.6M | 2.4% | — | — | 1 qtr | First report 0 |
BK OF AMERICA CORP | 2.1M | $53M | 2.4% | $20.58 | 0.00% | 1 qtr | First report 0 |
MILLER VALUE PARTNERS, LLC manages $2.2B across 102 positions as of Q4 2018. Top holdings: AMZN (5.4%), RH (5.4%), GNW (4.5%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3.5/5.0.
First quarter we have for this fund: 102 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $2.2B across 102 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR